持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/07/18 | 8,190 | 8,190 | 8,070 | 8,130 | +50 | +0.6% | 8,600 |
| 2018/07/17 | 7,980 | 8,120 | 7,960 | 8,080 | +180 | +2.3% | 23,000 |
| 2018/07/13 | 7,800 | 7,940 | 7,800 | 7,900 | +120 | +1.5% | 10,200 |
| 2018/07/12 | 7,840 | 7,880 | 7,780 | 7,780 | ±0 | ±0% | 10,500 |
| 2018/07/11 | 7,850 | 7,850 | 7,730 | 7,780 | -100 | -1.3% | 13,100 |
| 2018/07/10 | 7,920 | 8,100 | 7,880 | 7,880 | -40 | -0.5% | 18,000 |
| 2018/07/09 | 7,840 | 7,980 | 7,790 | 7,920 | +80 | +1% | 16,600 |
| 2018/07/06 | 7,880 | 7,910 | 7,810 | 7,840 | +40 | +0.5% | 14,200 |
| 2018/07/05 | 7,890 | 7,930 | 7,760 | 7,800 | -120 | -1.5% | 9,600 |
| 2018/07/04 | 7,700 | 7,950 | 7,690 | 7,920 | +130 | +1.7% | 12,300 |
| 2018/07/03 | 7,810 | 7,850 | 7,720 | 7,790 | -50 | -0.6% | 20,000 |
| 2018/07/02 | 8,070 | 8,090 | 7,810 | 7,840 | -230 | -2.9% | 16,400 |
| 2018/06/29 | 8,100 | 8,140 | 7,860 | 8,070 | ±0 | ±0% | 19,400 |
| 2018/06/28 | 8,160 | 8,160 | 8,040 | 8,070 | -120 | -1.5% | 28,500 |
| 2018/06/27 | 8,200 | 8,250 | 8,160 | 8,190 | ±0 | ±0% | 13,600 |
| 2018/06/26 | 8,090 | 8,190 | 8,050 | 8,190 | +140 | +1.7% | 11,800 |
| 2018/06/25 | 8,190 | 8,190 | 8,020 | 8,050 | -150 | -1.8% | 11,000 |
| 2018/06/22 | 8,230 | 8,230 | 8,180 | 8,200 | +10 | +0.1% | 18,700 |
| 2018/06/21 | 8,050 | 8,260 | 8,050 | 8,190 | +40 | +0.5% | 17,200 |
| 2018/06/20 | 8,020 | 8,180 | 8,020 | 8,150 | +40 | +0.5% | 16,600 |
| 2018/06/19 | 8,190 | 8,190 | 8,090 | 8,110 | -20 | -0.2% | 10,400 |
| 2018/06/18 | 8,200 | 8,200 | 8,090 | 8,130 | -30 | -0.4% | 10,000 |
| 2018/06/15 | 8,190 | 8,260 | 8,130 | 8,160 | -110 | -1.3% | 25,800 |
| 2018/06/14 | 8,300 | 8,330 | 8,220 | 8,270 | -100 | -1.2% | 18,200 |
| 2018/06/13 | 8,200 | 8,430 | 8,170 | 8,370 | +210 | +2.6% | 26,900 |
| 2018/06/12 | 8,050 | 8,190 | 8,020 | 8,160 | +150 | +1.9% | 22,700 |
| 2018/06/11 | 7,980 | 8,040 | 7,940 | 8,010 | +110 | +1.4% | 7,300 |
| 2018/06/08 | 7,850 | 7,930 | 7,830 | 7,900 | -10 | -0.1% | 23,300 |
| 2018/06/07 | 7,870 | 7,950 | 7,790 | 7,910 | +100 | +1.3% | 13,800 |
| 2018/06/06 | 7,850 | 7,870 | 7,760 | 7,810 | -100 | -1.3% | 19,500 |
| 2018/06/05 | 7,970 | 7,970 | 7,850 | 7,910 | -10 | -0.1% | 12,300 |
| 2018/06/04 | 7,890 | 7,990 | 7,850 | 7,920 | +160 | +2.1% | 25,100 |
| 2018/06/01 | 7,700 | 7,840 | 7,690 | 7,760 | +20 | +0.3% | 15,400 |
| 2018/05/31 | 7,730 | 7,750 | 7,700 | 7,740 | -20 | -0.3% | 29,800 |
| 2018/05/30 | 7,780 | 7,850 | 7,750 | 7,760 | -170 | -2.1% | 16,200 |
| 2018/05/29 | 7,920 | 7,970 | 7,860 | 7,930 | -50 | -0.6% | 13,900 |
| 2018/05/28 | 8,090 | 8,100 | 7,950 | 7,980 | -110 | -1.4% | 12,400 |
| 2018/05/25 | 8,060 | 8,140 | 8,060 | 8,090 | -40 | -0.5% | 12,300 |
| 2018/05/24 | 8,260 | 8,270 | 8,130 | 8,130 | -70 | -0.9% | 14,100 |
| 2018/05/23 | 8,170 | 8,230 | 8,120 | 8,200 | +10 | +0.1% | 17,400 |
| 2018/05/22 | 8,090 | 8,230 | 8,090 | 8,190 | +70 | +0.9% | 20,300 |
| 2018/05/21 | 8,160 | 8,230 | 8,090 | 8,120 | -110 | -1.3% | 18,500 |
| 2018/05/18 | 8,270 | 8,280 | 8,170 | 8,230 | -10 | -0.1% | 21,200 |
| 2018/05/17 | 8,090 | 8,240 | 8,070 | 8,240 | +200 | +2.5% | 31,000 |
| 2018/05/16 | 8,000 | 8,070 | 7,980 | 8,040 | +80 | +1% | 22,100 |
| 2018/05/15 | 7,750 | 8,040 | 7,750 | 7,960 | +210 | +2.7% | 40,200 |
| 2018/05/14 | 7,580 | 7,840 | 7,440 | 7,750 | +50 | +0.6% | 46,600 |
| 2018/05/11 | 7,620 | 7,730 | 7,620 | 7,700 | +80 | +1% | 13,200 |
| 2018/05/10 | 7,730 | 7,740 | 7,590 | 7,620 | -110 | -1.4% | 20,900 |
| 2018/05/09 | 7,770 | 7,800 | 7,680 | 7,730 | -50 | -0.6% | 27,300 |
1551～
1600
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
